Cerence's Q2 revenue slightly decreased year-over-year but was above the high end of the guidance range due to OEM-related adjustments. The company is lowering its FY24 guidance and withdrawing its multi-year plan. A Goodwill impairment charge of approximately $252 million was included in Q2 results. The company sees initial success with new generative AI products and early validation of its next-gen platform.
Q2 revenue was above the high end of the guidance range due to OEM-related adjustments.
FY24 guidance was lowered and multi-year plan was withdrawn.
Q2 results included a Goodwill impairment charge of approximately $252 million.
Early success with new generative AI products and validation of next-gen platform reported.
For the fiscal quarter ending June 30, 2024, revenue is expected to be in the range of $66 million to $72 million. GAAP net income is expected to be in the range of ($4) million to $2 million. Adjusted EBITDA is expected to be in the range of approximately $5 million to $11 million. For the full fiscal year ending September 30, 2024, the company expects revenue to be in the range of $318 million to $332 million which includes an estimated $30 million of fixed contracts. GAAP Net loss is expected to be in the range of ($256) million to ($242) million. Adjusted EBITDA is expected to be in the range of approximately $58 million to $72 million.
Visualization of income flow from segment revenue to net income